EyePoint Pharmaceuticals, Inc. (EYPT) PT Raised to $4.50 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts EYPT Hot Sheet
Price: $13.48 -0.37%
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
16 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
H.C. Wainwright analyst Raghuram Selvaraju raised the price target on EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) to $4.50 (from $2.75) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Wilmar International Ltd. (WIL:SP) (WLMIY) PT Raised to SGD3.70 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
